GELSYN-3 SODIUM HYALURONATE 16.8 MG / 2 ML INJECTION 2 ML

Report

• Report Number: MW5168248
• Event Type: Injury
• Date Received: March 26, 2025
• Report Date: March 19, 2025
• Manufacturer: IBSA INSTITUT BIOCHIMIQUE SA
• Product Code: MOZ
• Adverse Event: Yes
• Report Source: Voluntary report
• Reporter Location: US
• Reporter Occupation: UNKNOWN
• Health Professional: *

Narratives

Description of Event or Problem · 0

THE USER WAS CALLING IN NEEDING ASSISTANCE WITH THIS PHYSICIAN ASSISTANT (PA), BUT THEY STATED THEY WORKED IN A REHAB FACILITY. SINCE THIS MEDICATION WAS PRESCRIBED FOR A PATIENT IN A REHAB FACILITY, THIS IS BEING REPORTED AS A POTENTIAL ADVERSE EVENT (PAE). HEALTH CARE PROFESSIONAL (HCP) DID NOT CONSENT TO FOLLOW UP, NO FURTHER INFORMATION PROVIDED OR AVAILABLE REGARDING THIS REPORT. (B)(4).

Devices

Seq	Brand	Generic	Product Code	Manufacturer	Model	Lot	UDI-DI
2657651	GELSYN-3 SODIUM HYALURONATE 16.8 MG / 2 ML INJECTION 2 ML	ACID, HYALURONIC, INTRAARTICULAR	MOZ	IBSA INSTITUT BIOCHIMIQUE SA

Patients

Seq	Age	Sex	Outcome	Treatment
1	NA	Unknown

Terms

Patient problem · 1

• Insufficient Information

Type of report · 1

• Initial submission